RxDoctor Payments Data

Keena Harrison

Psychiatric/Mental Health · San Jacinto, CANPI 1790334696

Payments from drug & device makers

$5,998in general payments, 2019–2025

Across 171 payments — averaging $35.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$3K
  • AbbVie$1K
  • Painteq LLC$842
  • Hikma Pharmaceuticals USA$206
  • Scilex Pharmaceuticals Inc.$190
  • Alkermes, Inc.$43
  • plus $247 from 10 others

What the payments were for

  • Travel & lodging$1,13519%
  • Food & beverage$4,31372%
  • Education$5509%
  • Gifts$00%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,998 in reported general payments places this provider in the 90th percentile of 2,433 psychiatric/mental health providers in California.

See all psychiatric/mental health providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
Abilify MaintenaAripiprazole29$79,993
Invega SustennaPaliperidone Palmitate13$44,820
Aripiprazole37$3,289
Haloperidol14$1,597
Bupropion XlBupropion Hcl42$1,405
Divalproex Sodium ErDivalproex Sodium17$878
Ziprasidone Hcl12$677
LoxapineLoxapine Succinate12$635
Haloperidol Decanoate14$572
Ramelteon11$567
Trazodone Hcl32$415
Mirtazapine40$391
Gabapentin29$374
Benztropine Mesylate24$244
Quetiapine Fumarate27$233

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena$21$79,99329 claims
Teva Pharmaceuticals USA, Inc.Loxapine$28$63512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,433 psychiatric/mental health providers in California.

Other psychiatric/mental health in San Jacinto

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →